Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
reduce the time to reach clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases;
reduce the time to reach clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases
Dernière mise à jour : 2017-04-07
Fréquence d'utilisation : 1
Qualité :
[7] pokyn výboru pro veterinární léčivé přípravky (cvmp): environmental risk assessment for veterinary medicinal products other than gmo containing and immunological products (emea/cvmp/055/96-final) guidelines on environmental impact assessment (eias) for veterinary medicinal products – phase i and ii (cvmp/vich/592/98-final; cvmp/vich/790/03-final http://www.emea.eu.int).
[7] (leitlinie des ausschusses für tierarzneimittel) (cvmp) note for guidance: environmental risk assessment for veterinary medicinal products other than gmo containing and immunological products (emea/cvmp/055/96-final) guidelines on environmental impact assessment (eias) for veterinary medicinal products – phase i and ii (cvmp/vich/592/98-final; cvmp/vich/790/03-final http://www.emea.eu.int)
Dernière mise à jour : 2014-10-23
Fréquence d'utilisation : 6
Qualité :
